The Granata Bio Team
More than 130 years of fertility experience working to reimagine what’s possible in reproductive health
-
Licia Ambrosone is a Clinical Trials Manager at Granata Bio, where she supports the execution of clinical development programs through strong operational oversight, CRO and site coordination, and regulatory compliance. With experience managing global clinical trials across multiple phases, Licia brings a structured, quality-driven approach to advancing reproductive-health therapies. Learn more and connect with Licia on LinkedIn.
-
Marc Chung is a Co-Founder of Granata Bio, where he leads strategic planning, partnerships, and business development to drive growth and long-term value. With extensive experience in healthcare consulting, analytics, and account strategy, including roles at Deloitte, Quintiles Consulting, Outcome Health, and Komodo Health, Marc bridges deep industry insight with commercial strategy to help bring innovative reproductive therapies to market. He holds a BA from Johns Hopkins University, MPH from the Yale School of Public Health and an MBA from the Yale School of Management. Learn more and connect with Marc on LinkedIn.
-
With more than two decades of experience in gynecology and assisted reproductive technologies, Dr. Barbara Cometti leads the scientific affairs strategy at Granata Bio. She oversees program design, translational research, and regulatory alignment to drive the development of novel fertility therapies. Prior to joining Granata Bio, Barbara was Senior R&D Scientific Affairs Manager at IBSA Institut Biochimique, where she guided ART programs and published important work on fertility hormone clinical studies and reproductive endocrinology. Learn more and connect with Barbara on LinkedIn.
-
Shelly Frazier supports Granata Bio’s leadership as Executive Coordinator & Quality Assurance Administrator, ensuring operational efficiency, cross-functional alignment, and process rigor. With nearly two decades of previous administrative and project leadership experience at EMD Serono, she brings organizational discipline, attention to detail, and a collaborative mindset to every aspect of her role. Learn more and connect with Shelly on LinkedIn.
-
As Senior Manager, Product Development at Granata Bio, Lauren Miller provides program management oversight and support to drive product development for new therapies in the Granata Bio pipeline. Known for translating complex R&D goals into structured development programs, Lauren’s goal is to provide on-time delivery of milestones that align with corporate strategy. As a former Pre-Clinical Senior Scientist, Lauren has a unique skillset and experiences that shape her approach to program management. Lauren’s career spans multiple development areas, including cell line development for biosimilars and enzyme replacement therapies, cell and gene therapy, and nonclinical pharmacology. Lauren is a PMP-certified Program Manager.
-
Jeanie McCoy is a Clinical Trial Associate at Granata Bio with more than five years of experience in clinical trial operations and healthcare program management. She supports studies across the full clinical lifecycle, ensuring regulatory compliance, TMF integrity, and strong coordination among internal teams, CROs, and sites. Prior to Granata Bio, Jeanie held clinical research roles at LumaBridge and ICON plc and brings a patient-centered, quality-driven approach to advancing clinical development programs. Learn more and connect with Jeanie on LinkedIn.
-
As Product Development Manager at Granata Bio, Leigh plays a key role in advancing clinical and drug development programs from early research through late-stage trials. She applies a strong foundation in biological research, project coordination, and cross-functional execution to her role, developing strategic plans, driving program operations, and ensuring alignment across internal teams, external partners, and regulatory requirements. Prior to joining Granata Bio, she supported molecular biology research programs at MIT, Dartmouth College, and the Howard Hughes Medical Institute, where she helped establish new lab operations and streamline experimental workflows. Leigh holds a BS in Biology from Merrimack College. Learn more and connect with Leigh on LinkedIn.
-
As Senior Manager, Quality Assurance & Regulatory Affairs at Granata Bio, Stuart Morgan brings deep expertise in GxP compliance, vendor oversight, and quality systems execution to support the company's clinical- and commercial-stage programs. He supports the development and maintenance of the company's Quality Management System, ensuring compliance across GMP, GCP, and GLP activities within a global, partner-driven operating model. Stuart is known for operational rigor, inspection readiness, and execution in complex environments. Learn more and connect with Stuart on LinkedIn.
-
Sarah Faranda is Co-Founder and Chief Development Officer of Granata Bio, where she shapes the company’s development and commercial initiatives in fertility and women’s health. With over 14 years of strategic marketing experience across global and U.S. pharmaceutical brands, Sarah previously led launches and brand transformations for Teva Women’s Health, Ferring Fertility and EMD Serono. Learn more and connect with Sarah on LinkedIn.
-
In this role as Chief Operating Officer, Steve applies more than 20 years of operational leadership and commercial strategy experience to oversee operations, business development, and growth initiatives that drive execution across commercialization and day-to-day business performance. He also sits on the board of directors for Granata Bio's partner organizations, Oviva Therapeutics and GTE Bio, LLC, where he provides strategic and operational guidance to progress new early-stage therapeutic options within the Women's Health Industry. Learn more and connect with Steve on LinkedIn.
-
As Director of Product Development at Granata Bio, Stephanie Moebius drives strategies that align regulatory, CMC, clinical, and commercial priorities as the company advances new therapies toward market. Her deep experience across product development, marketing, and market access, combined with a collaborative, influential approach, enables Stephanie to integrate scientific rigor with commercial insight, build consensus among diverse teams, and translate strategic priorities into measurable impact. Learn more and connect with Stephanie on LinkedIn.
-
Dave Paller is CFO and Co-Founder of Granata Bio, where he leads business development, financial operations, and strategic planning to support the company’s mission of expanding access to fertility therapeutics. With a background in bioengineering, medical-device development, and academic research, Dave bridges scientific insight with commercial strateg to help turn innovative reproductive-health concepts into viable, patient-centered solutions. Learn more and connect with Dave on LinkedIn.
-
As CEO and Co-Founder of Granata Bio, Evan leads the company’s mission to bring innovation back to reproductive health. He combines experience across biotech, pharma, and medical devices with a proven track record in product launch, commercialization, and growth strategy to expand access to fertility care. Learn more and connect with Evan on LinkedIn.
-
Zeb Younes brings over 25 years of biopharmaceutical regulatory and CMC experience to Granata Bio. As Chief Regulatory Officer, CMC, she leads the design and execution of global regulatory CMC strategies for various products, aligning cross-functional teams to drive quality, compliance, and efficient development from early stage through registration. Her experience spans recombinant proteins, hormones, monoclonal antibodies, and tissue, cell, and gene therapies. Prior to Granata Bio, she led global regulatory and development teams and supported GMP facility readiness and inspection activities. Learn more and connect with Zeb on LinkedIn.